Opportunity Information: Apply for RFA DK 20 029

The Kidney Precision Medicine Project (KPMP) Central Hub funding opportunity (RFA-DK-20-029) is an NIH cooperative agreement (U24; clinical trial not allowed) aimed at running the operational and scientific backbone for the broader KPMP program. The central purpose is to support the KPMP participant cohort and ensure that clinical information and biospecimens collected across the project are handled in a consistent, high-quality, and secure way. In practice, the Central Hub is expected to serve as the organizing center that receives, curates, and de-identifies clinical data and sample-related information from the network, while also providing the coordination, infrastructure, and oversight needed to keep a complex, multi-site effort working smoothly and producing usable, harmonized outputs.

A major focus of the Central Hub is end-to-end data and sample coordination: collecting both existing and newly generated clinical data and biospecimens tied to KPMP participants, making sure they are properly de-identified, and managing the associated workflows so that the information can be used across collaborating teams. Beyond basic collection, the Hub is responsible for building and maintaining scientific and technical infrastructure that supports the program, including quality control processes that ensure data integrity and comparability across sites. This includes the kinds of standardization, tracking, documentation, and validation steps that are essential when multiple institutions are generating and contributing clinical and tissue-derived data intended to be integrated into a single, program-wide resource.

The Central Hub is designed to work closely with several other KPMP components: Recruitment Sites (RS), Tissue Interrogation Sites (TIS), and the Kidney Tissue Atlas Coordinating Center (KTACC). Together, these groups will obtain and evaluate kidney biopsies from people with acute kidney injury (AKI) or chronic kidney disease (CKD). The broader scientific objective is to create a Kidney Tissue Atlas and use it to define disease subgroups and identify the key cells, interstitial features, molecular pathways, and therapeutic targets that could lead to more precise, mechanism-based treatments. The Central Hub role in this ecosystem is to enable and accelerate that science by keeping operations coordinated, ensuring consistent standards and quality controls, and providing project management and administrative support so that the pipeline from participant recruitment to tissue assessment to atlas construction remains aligned and efficient.

This FOA is explicitly not intended to support clinical trials under this award mechanism. Instead, it emphasizes coordination, infrastructure, rigorous data/sample handling, and collaborative support functions that make the program’s translational and atlas-building goals feasible. As a cooperative agreement, it also implies substantial NIH involvement in the ongoing direction and stewardship of the project, with awardees expected to work in close partnership with NIH and the other funded components of KPMP rather than operating as a fully independent, stand-alone research project.

Eligibility is broad and includes many types of U.S.-based organizations and governments, such as state, county, city/township, and special district governments; public and state-controlled and private institutions of higher education; independent school districts; federally recognized Native American tribal governments and other tribal organizations; public housing authorities/Indian housing authorities; nonprofits (both 501(c)(3) and non-501(c)(3)); for-profit organizations other than small businesses; small businesses; and other eligible entities. The FOA also highlights additional eligible applicant categories such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, regional organizations, eligible federal agencies, and U.S. territories or possessions. At the same time, non-domestic (non-U.S.) entities and non-domestic components of U.S. organizations are not eligible to apply, though foreign components (as defined by the NIH Grants Policy Statement) may be allowable within an otherwise eligible application.

Key administrative details from the source information include the sponsoring agency (National Institutes of Health), the assistance listing/CFDA number 93.847, and the original closing date of September 23, 2021. The activity aligns with health-related research support (listed under Food and Nutrition, Health in the source categorization), and the central deliverable implied by the program description is a well-coordinated, quality-controlled, de-identified clinical and biospecimen-linked data resource that can be integrated with tissue interrogation outputs to build the Kidney Tissue Atlas and drive discovery of clinically meaningful kidney disease subtypes and therapeutic targets.

  • The National Institutes of Health in the food and nutrition, health sector is offering a public funding opportunity titled "Kidney Precision Medicine Project Central Hub (U24 Clinical Trial Not Allowed)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.847.
  • This funding opportunity was created on 2021-04-22.
  • Applicants must submit their applications by 2021-09-23. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for RFA DK 20 029

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Kidney Precision Medicine Project (KPMP) Central Hub (RFA-DK-20-029) - FAQs

What is the KPMP Central Hub funding opportunity?

The KPMP Central Hub funding opportunity (RFA-DK-20-029) supports an NIH cooperative agreement (U24; clinical trial not allowed) to operate the central organizing and coordinating backbone for the broader Kidney Precision Medicine Project (KPMP) program.

What is the main purpose of the Central Hub within KPMP?

The Central Hub is intended to support the KPMP participant cohort and ensure clinical information and biospecimens collected across the project are handled in a consistent, high-quality, and secure manner. It functions as the organizing center for receiving, curating, and de-identifying clinical data and sample-related information and for keeping a complex multi-site program coordinated and aligned.

What type of award mechanism is used for this opportunity?

This opportunity uses an NIH cooperative agreement mechanism (U24). A cooperative agreement indicates substantial NIH involvement in the ongoing direction and stewardship of the project.

Are clinical trials allowed under this FOA?

No. The FOA is explicitly described as "clinical trial not allowed" and is not intended to support clinical trials under this award mechanism.

What kinds of activities does the Central Hub support if not clinical trials?

The FOA emphasizes coordination, infrastructure, rigorous data and sample handling, quality control, and collaborative support functions that enable KPMP's translational and atlas-building goals. The Hub is expected to provide the operational and scientific backbone rather than operate as a stand-alone clinical study.

What does "end-to-end data and sample coordination" mean in this context?

It refers to managing the full workflow for clinical data and biospecimens tied to KPMP participants, including collecting both existing and newly generated information, ensuring proper de-identification, and managing processes so data and sample-related information can be used consistently across collaborating teams.

What are the Central Hub's responsibilities for data handling?

Based on the description, the Central Hub is expected to receive, curate, and de-identify clinical data and sample-related information from the KPMP network, and to manage the workflows required to make those data usable in a program-wide, harmonized way.

What are the Central Hub's responsibilities for biospecimens and sample-related information?

The Hub is expected to coordinate biospecimen-linked information across sites, ensuring consistent standards, secure handling, de-identification of associated information, and workflow management so that biospecimen-related data can be integrated across the program.

What is meant by "de-identification" in the Central Hub role?

The FOA indicates the Central Hub is responsible for de-identifying clinical data and sample-related information received from the network so it can be curated and used across teams in a secure manner.

What kind of infrastructure is the Central Hub expected to build and maintain?

The Central Hub is responsible for building and maintaining scientific and technical infrastructure that supports KPMP program operations, including systems and processes for coordination, tracking, documentation, validation, and quality control that enable integration across multiple institutions.

What does quality control mean for this program?

Quality control in this FOA includes processes to ensure data integrity and comparability across sites, such as standardization, tracking, documentation, and validation steps needed when multiple institutions contribute clinical and tissue-derived data intended for a single harmonized resource.

Why is standardization across sites emphasized?

The program involves multiple institutions generating and contributing clinical and tissue-derived data. Standardization and validation steps are necessary so outputs can be integrated into a single program-wide resource with consistent quality and comparability.

Which KPMP components is the Central Hub expected to work with?

The Central Hub is designed to work closely with Recruitment Sites (RS), Tissue Interrogation Sites (TIS), and the Kidney Tissue Atlas Coordinating Center (KTACC).

What do Recruitment Sites (RS) and Tissue Interrogation Sites (TIS) do in the broader program?

As described, these groups (along with KTACC) will obtain and evaluate kidney biopsies from people with acute kidney injury (AKI) or chronic kidney disease (CKD). The Central Hub supports coordination and standardized handling of linked clinical and sample-related information across the network.

What is KTACC in relation to the Central Hub?

KTACC stands for the Kidney Tissue Atlas Coordinating Center. The Central Hub is expected to work closely with KTACC and other KPMP components to keep the program aligned and to support atlas-building efforts through coordinated operations and high-quality data/sample handling.

What is the broader scientific objective of KPMP supported by the Central Hub?

The broader objective is to create a Kidney Tissue Atlas and use it to define disease subgroups and identify key cells, interstitial features, molecular pathways, and therapeutic targets that could enable more precise, mechanism-based treatments. The Central Hub enables and accelerates this by coordinating operations and producing harmonized, quality-controlled, de-identified resources.

What patient populations are referenced in the program description?

The program description references people with acute kidney injury (AKI) or chronic kidney disease (CKD), from whom kidney biopsies will be obtained and evaluated by the collaborating KPMP components.

What are the expected deliverables or outputs of the Central Hub?

The implied central deliverable is a well-coordinated, quality-controlled, de-identified clinical and biospecimen-linked data resource that can be integrated with tissue interrogation outputs to build the Kidney Tissue Atlas and support discovery of clinically meaningful disease subtypes and therapeutic targets.

How does the cooperative agreement structure affect how the project is run?

Because this is a cooperative agreement, the FOA indicates substantial NIH involvement in ongoing direction and stewardship. Awardees are expected to work in close partnership with NIH and other funded KPMP components rather than operating as a fully independent project.

Who is the sponsoring agency for this funding opportunity?

The sponsoring agency is the National Institutes of Health (NIH).

What is the Assistance Listing (CFDA) number for this opportunity?

The Assistance Listing/CFDA number provided is 93.847.

What was the original closing date listed for this opportunity?

The original closing date provided is September 23, 2021.

What types of organizations are eligible to apply?

Eligibility is broad and includes many U.S.-based organizations and governments, including: state, county, city/township, and special district governments; public and state-controlled and private institutions of higher education; independent school districts; federally recognized Native American tribal governments and other tribal organizations; public housing authorities/Indian housing authorities; nonprofits (501(c)(3) and non-501(c)(3)); for-profit organizations other than small businesses; small businesses; and other eligible entities.

Are minority-serving institutions and community-based organizations included in eligible applicants?

Yes. The FOA highlights additional eligible applicant categories such as Alaska Native and Native Hawaiian Serving Institutions, AANAPISIs, Hispanic-serving Institutions, HBCUs, TCCUs, faith-based or community-based organizations, regional organizations, eligible federal agencies, and U.S. territories or possessions.

Are non-U.S. (non-domestic) entities eligible to apply?

No. Non-domestic (non-U.S.) entities and non-domestic components of U.S. organizations are not eligible to apply based on the provided description.

Are foreign components allowed in any way?

Foreign components (as defined by the NIH Grants Policy Statement) may be allowable within an otherwise eligible application, even though non-domestic entities and non-domestic components of U.S. organizations are not eligible to apply.

How is this opportunity categorized in the source information?

The activity aligns with health-related research support and is listed under Food and Nutrition, Health in the source categorization.

What makes the Central Hub different from a typical single-site research project?

The Central Hub is described as an organizing center for a complex, multi-site effort. Its role is to coordinate, standardize, curate, de-identify, and quality-control program-wide clinical and biospecimen-linked information, and to provide project management and administrative support across collaborating KPMP components.

What kinds of support functions are explicitly emphasized for the Central Hub?

The FOA emphasizes coordination, infrastructure, oversight, project management, administrative support, secure and consistent handling of clinical information and biospecimens, and program-wide quality control processes to ensure harmonized, usable outputs.

What is the relationship between the Central Hub and the Kidney Tissue Atlas?

The Central Hub supports the atlas-building effort by ensuring clinical and biospecimen-linked information is consistently handled, de-identified, curated, quality-controlled, and harmonized so it can be integrated with tissue interrogation outputs and used for Kidney Tissue Atlas construction and downstream discovery.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Food and Nutrition, Health

Next opportunity: SBIR E-Learning for HAZMAT and Emergency Response (R43/R44 Clinical Trial Not Allowed)

Previous opportunity: Social and Behavior Change (SBC) Research

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA DK 20 029

 

Applicants also applied for:

Applicants who have applied for this opportunity (RFA DK 20 029) also looked into and applied for these:

Funding Opportunity
Kidney Precision Medicine Project Tissue Interrogation Sites (U01 Clinical Trial Not Allowed) Apply for RFA DK 20 028

Funding Number: RFA DK 20 028
Agency: National Institutes of Health
Category: Food and Nutrition, Health
Funding Amount: Case Dependent
Kidney Precision Medicine Project Recruitment Sites (U01 Clinical Trial Not Allowed) Apply for RFA DK 20 026

Funding Number: RFA DK 20 026
Agency: National Institutes of Health
Category: Food and Nutrition, Health
Funding Amount: Case Dependent
Kidney Precision Medicine Project Kidney Tissue Atlas Coordinating Center (U01 Clinical Trial Not Allowed) Apply for RFA DK 20 027

Funding Number: RFA DK 20 027
Agency: National Institutes of Health
Category: Food and Nutrition, Health
Funding Amount: Case Dependent
NIDDK Short-Term Research Experience Program to Unlock Potential (STEP-UP) (R25 Clinical Trial Not Allowed) Apply for RFA DK 21 023

Funding Number: RFA DK 21 023
Agency: National Institutes of Health
Category: Food and Nutrition, Health
Funding Amount: Case Dependent
Support for Small Business Innovation Research (SBIR) to Develop New Technologies for Development and Integration of Novel Components for Open and Closed Loop Hormone Replacement Platforms for T1D Therapy (R43/R44 Clinical Trial Not Allowed) Apply for RFA DK 21 011

Funding Number: RFA DK 21 011
Agency: National Institutes of Health
Category: Food and Nutrition, Health
Funding Amount: Case Dependent
Comprehensive Care for Adults with Type 2 Diabetes Mellitus from Populations with Health Disparities (R01 Clinical Trial Optional) Apply for PA 21 232

Funding Number: PA 21 232
Agency: National Institutes of Health
Category: Food and Nutrition, Health
Funding Amount: $500,000
Characterization of Islet-derived Extracellular Vesicles for Improved Detection, Monitoring, Classification, and Treatment of Type 1 Diabetes (R01 Clinical Trial Not Allowed) Apply for RFA DK 21 016

Funding Number: RFA DK 21 016
Agency: National Institutes of Health
Category: Food and Nutrition, Health
Funding Amount: $500,000
Support for Small Business Innovation Research (SBIR) to Develop New Methods and Technologies for Assessment of Risk and for Early Diagnosis and Prognosis of Type 1 Diabetes (R43/R44 Clinical Trial Not Allowed) Apply for RFA DK 21 021

Funding Number: RFA DK 21 021
Agency: National Institutes of Health
Category: Food and Nutrition, Health
Funding Amount: Case Dependent
Identification and Characterization of Bioactive Microbial Metabolites for Advancing Research on Microbe-Diet-Host Interactions Knowledgebase Management Center (U24 Clinical Trial Not Allowed) Apply for RFA DK 21 014

Funding Number: RFA DK 21 014
Agency: National Institutes of Health
Category: Food and Nutrition, Health
Funding Amount: Case Dependent
Understanding and Targeting the Pathophysiology of Youth-onset Type 2 Diabetes Clinical Centers (U01 Clinical Trial Not Allowed) Apply for RFA DK 21 002

Funding Number: RFA DK 21 002
Agency: National Institutes of Health
Category: Food and Nutrition, Health
Funding Amount: Case Dependent
Regenerative Medicine Innovation Project (RMIP) Investigator-Initiated Clinical Trials (UG3/UH3 Clinical Trial Required) Apply for RFA HL 22 014

Funding Number: RFA HL 22 014
Agency: National Institutes of Health
Category: Food and Nutrition, Health
Funding Amount: Case Dependent
Continuation of The Collaborative Islet Transplantation Registry (U01 Clinical Trial Not Allowed) Apply for RFA DK 21 013

Funding Number: RFA DK 21 013
Agency: National Institutes of Health
Category: Food and Nutrition, Health
Funding Amount: $500,000
Understanding and Targeting the Pathophysiology of Youth-onset Type 2 Diabetes Biostatistics Research Center (U01 Clinical Trial Not Allowed) Apply for RFA DK 21 003

Funding Number: RFA DK 21 003
Agency: National Institutes of Health
Category: Food and Nutrition, Health
Funding Amount: $25,000,000
Pilot and Feasibility Studies to Improve Technology Adoption and Reduce Health Disparities in Type 1 Diabetes Mellitus (R01 Clinical Trial Required) Apply for RFA DK 21 018

Funding Number: RFA DK 21 018
Agency: National Institutes of Health
Category: Food and Nutrition, Health
Funding Amount: Case Dependent
Cardiovascular Biorepository for Type 1 Diabetes (U24 Clinical Trial Not Allowed) Apply for RFA DK 21 010

Funding Number: RFA DK 21 010
Agency: National Institutes of Health
Category: Food and Nutrition, Health
Funding Amount: Case Dependent
New Investigators to Promote Workforce Diversity in Genomics, Bioinformatics, or Bioengineering and Biomedical Imaging Research (R01 Clinical Trial Optional) Apply for RFA HG 21 041

Funding Number: RFA HG 21 041
Agency: National Institutes of Health
Category: Food and Nutrition, Health
Funding Amount: Case Dependent
High-Resolution Exploration of the Human Islet Tissue Environment [HIRN Human Pancreas Analysis Consortium (HPAC)] (U01 - Clinical Trial Not Allowed) Apply for RFA DK 21 017

Funding Number: RFA DK 21 017
Agency: National Institutes of Health
Category: Food and Nutrition, Health
Funding Amount: $600,000
Limited Competition for the Continuation of Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed) Apply for RFA DK 21 503

Funding Number: RFA DK 21 503
Agency: National Institutes of Health
Category: Food and Nutrition, Health
Funding Amount: $6,300,000
Small Grants for New Investigators to Promote Diversity in Health-Related Research (R21 Clinical Trial Optional) Apply for PAR 21 313

Funding Number: PAR 21 313
Agency: National Institutes of Health
Category: Food and Nutrition, Health
Funding Amount: $125,000
National Program for the Career Development Of Physician Scientists in Diabetes Research (Diabetes - Docs) (K12 Clinical Trial Optional) Apply for RFA DK 21 019

Funding Number: RFA DK 21 019
Agency: National Institutes of Health
Category: Food and Nutrition, Health
Funding Amount: $1,300,000

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA DK 20 029", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: